Council for Medical Schemes (CMS)

Circular 31 of 2021: Section 61 declaration for Designate Service Providers

CMS published Government Gazette Notice 214 of 2021 on 23 April 2021, following the Appeal Board judgement which ordered Council to finalise the section 61 of the Medical Schemes Act (131 of 1998) process, pertaining to the selection process of Designated Service Providers (DSP’s) and matters relating to the imposition of excessive co-payments.

PMB definition guideline: COVID-19 v6

The World Health Organization (WHO) was alerted of a cluster of pneumonia of unknown aetiology in patients in Wuhan City, Hubei Province of China on 31 December 2019.

Bronchopneumonia in Children

Bronchopneumonia is the most common clinical manifestation of pneumonia in the pediatric population, and the leading cause of death in children under the age of 5 years

Chronic lymphocytic leukemia (CLL)

In this issue of CMScript, we focus on Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, and it rarely occurs in children.

Circular 50 of 2018: Demarcation Exemption Appeal Outcomes

CMS welcomes Appeal Board decisions not to exempt Discovery Health (Pty) Ltd & Agility Insurance Administrators (Pty) Ltd's Primary Care products

Quarterly Reports for the Period ending 31 March 2018

INTRODUCTION
This report details the quarterly statutory returns results for the period ended 31 March 2018. Budget information for the first quarter of 2018 is also provided for comparative purposes. The report reflects consolidated industry data only, as data on an individual scheme level has not been audited and can therefore not be made available to the public.
The Council for Medical Schemes (CMS) provides no assurance on the reliability of budget figures contained in this report.
It should also be noted that information for Community Medical Aid Scheme (COMMED) has been excluded from any comparison data from 2017.

Circular 42 of 2018: Draft Medical Schemes Consolidation Framework

This circular serve as an invite for comments and input by all interested stakeholders on the Draft Framework for Medical Schemes Consolidation. As indicated in Circular 33 of 2018, in 2017, the CMS appointed an actuarial firm to unsertake an impact analysis on medical schemes consolidatioin with a view of proposing a framework for consolidation in preparation for CMS participation within the identified NHI Ministerial and National Advisory Committees

SA Medical Schemes looking to change solvency ratio legislation

Do current solvency levels limit a medical scheme’s growth and inhibit expansion into low-income markets? One thing is for certain, there’s been a shift in global opinion about pre-determining the solvency ratios for private medical schemes. South Africa is no different.

Annual Statutory Returns development for the 2018 financial year.

The Office of the Registrar (Office) is currently in the process of enhancing the format of the Annual Statutory Return for the 2018 financial year. To read the circular

Focus on Gastric and Duodenal Ulcers

In this issue of CMScript we focus on Gastric and Duodenal Ulcers. They are one of the most common gastro-intestinal disorders is Peptic Ulcer Disease (PUD), with a global incidence and prevalence of 4.8%. PUD refers to the ulceration of the stomach or small intestine (duodenal) mucosa.

Cardiac (Heart) Failure

In this issue of CMScript, we focus on Cardiac (Heart) Failure. It is part of the Cardiovascular Diseases that are the leading cause of disabilities and deaths worldwide, accounting for 31% of total global deaths. Africa is at present a major contributor to the global burden of CVDs. In 2013, 5.5% of all the global CVD‑related deaths were in Africa. In South Africa, CVDs are the leading cause of death after HIV/AIDS. More South Africans die of CVDs than of all the cancers combined. CVDs are responsible for almost 1 in 6 deaths (17.3%) in the country.